# A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy

> **NCT01248403** · PHASE3 · COMPLETED · sponsor: **Krankenhaus Nordwest** · enrollment: 300 (actual)

## Conditions studied

- Advanced Gastric Cancer
- Esophagogastric Junction Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT01248403
- **Lead sponsor:** Krankenhaus Nordwest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2017-07
- **Final completion:** 2019-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248403, "A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01248403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*